Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Short chain fatty acid (SCFA)-hexosamine hybrids are utilized in metabolic glycoengineering.
• These compounds are emerging as potential drug candidates.
• Previous research demonstrated distinct cellular responses to single SCFA types.

Purpose of the Study:

• To investigate the cellular responses induced by SCFA-hexosamine hybrid molecules.
• To explore the impact of varying SCFA moieties and sugar modifications on biological activity.
• To elucidate the underlying molecular mechanisms of action.

Main Methods:

• A "mix and match" strategy to combine different SCFAs with core sugars.
• Microarray profiling to analyze transcriptional responses in MDA-MB-231 cells.
• Quantitative real-time PCR (qRT-PCR) and Western blot analysis for gene validation.
• AutoDock modeling to predict molecular interactions.

Main Results:

• Different SCFAs appended to the same sugar core altered biological activity.
• Regioisomeric modifications of ManNAc, GlcNAc, and GalNAc analogues elicited distinct transcriptional profiles.
• A core set of genes was coordinately regulated, while each analogue uniquely modulated a larger gene set.
• Validation confirmed differential gene expression for ID1, TP53, HPSE, NQO1, EGR1, and VEGFA.
• AutoDock modeling suggested direct interaction with the NF-kappaB pathway.

Conclusions:

• The SCFA-hexosamine template is a versatile platform for modulating biological activity.
• These hybrid molecules offer a flexible approach for developing new therapeutics.
• Understanding the dual gene regulation (core and unique) is key to therapeutic design.